Schedule of Outstanding Common Stock Warrants Activity (Details) |
6 Months Ended |
|---|---|
|
Mar. 31, 2025
$ / shares
shares
| |
| Common Stock Warrants | |
| Number of Shares, Balance beginning | shares | 15,387,050 |
| Weighted Average Exercise Price, Balance beginning | $ 0.016 |
| Number of Shares, Warrants granted | shares | |
| Weighted Average Exercise Price, Warrants granted | |
| Number of Shares, Warrants expired | shares | |
| Weighted Average Exercise Price, Warrants expired | |
| Number of Shares, Balance ending | shares | 15,387,050 |
| Weighted Average Exercise Price, Balance, ending | $ 0.016 |
| Number of Shares, Exercisable | 15,387,050 |
| Weighted Average Exercise Price, Exercisable | $ 0.016 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercisable number. No definition available.
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to non-option equity of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|